Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs.
Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!
| 3.The fifteenth avanced level workshop on PK/PD data analysis |
| Dates | 19 Mai 2013 → 23 Mai 2013 | [ID=524070]  |
| Lieu | Cambridge, Royaume-Uni |
| Résumé | This advanced and well established four-day residential course is designed to provide an interface between the computer analysis of PK and PD data and physiological concepts. The participants will practice pkpd concepts by means of the WinNonlin 6 and MAXSIM2 software. |
| Sujets | Pharmacodynamics, pharmacokinetics, Pharmaceutical, Scientist, Training, Education |
| Page web | http://www.rpharms.com/courses/pkpd-course.asp |
| Contact | Rachel Flower The Royal Pharmaceutical Society 1 Lambeth High Street London SE1 7JN; Tél.: [0207 572 2703]; Email.: events@rpharms.com |
| | |
| 4.EuroMedLab Milano 2013 — Congress of Clinical Chemistry and Laboratory Medicine |
| Dates | 19 Mai 2013 → 23 Mai 2013 | [ID=504930] |
| Lieu | Milan, Italie |
| Page web | http://www.milan2013.org/index.php |
| Sujets apparentés | Physique appliquée: Biophysique et génie biomédical |
| | |
| 5.IX EWDD — Ninth European Workshop in Drug Design |
| Dates | 19 Mai 2013 → 25 Mai 2013 | [ID=533686] |
| Lieu | Certosa di Pontignano, Siena, Italie |
| Résumé | The Ninth European Workshop in Drug Design will allow maximum 65 participating scientists to work closely with more than 20 leading researchers from both drug industry and academic institutions in exploring solutions to concrete problems encountered in the drug design and discovery process. Like in the previous editions the goal of the Workshop is to help participants to collect, interpret and use experimental data to design new drugs using new methods of molecular modeling in conjunction with synthetic feasibility concepts and metabolic pathways. Interaction of these studies with strategies adopted in the Pharmaceutical Industries, such as high-throughput screening, will be explored. |
| Sujets | Drug design, molecular dynamics, computer aided design |
| Page web | http://www3.unisi.it/EWDD/ |
| Contact | Email.: info9ewdd@gmail.com |
| Sujets apparentés | Modélisation moléculaire; Biochimie et chimie médicale |
| | |
| 6.Biosimilars Asia 2013 |
| Dates | 20 Mai 2013 → 23 Mai 2013 | [ID=535792] |
| Lieu | Shanghai, Chine |
| Résumé | IBC’s 4th Annual Biosimilars Asia 2013 is the region’s largest gathering of leading and future stakeholders. Lively debates, insightful case studies and in-depth market analysis provide maximum learning. Keep abreast of the latest in biosimilars development and commercial strategies. Engage with your peers in competing to bring affordable medicines to market. |
| Sujets | biosimilars, biomanufacturing, biotech, biologics, biology, drug discovery |
| Page web | http://www.biosimilarsasia.com |
| Contact | Rita Parasurum; Tél.: [6565082401]; Email.: rita.parasurum@ibcasia.com.sg |
| | |
| 7.2nd Pharma Legal Affairs Asia 2013 |
| Dates | 21 Mai 2013 → 23 Mai 2013 | [ID=535720] |
| Lieu | Shanghai, Chine |
| Sujets | Pharma Legal Affairs Asia, IP protection and licensing, Anti-Corruption in Pharmaceutical, Pharmaceutical Patent litigation, Pharmaceutical Legal Framework, Commercial Pharma Contract, Pharma patent, Pharmaaceutical Collaboration, Licensing In, Licensing Out |
| Page web | http://www.pharmalegalasia.com |
| Contact | Shanice Soh; Tél.: [+65 6508 2461]; Email.: shanice.soh@ibcasia.com.sg |
| | |
| 8.Statistical Process Control for Process Development and Validation — 2-day In-person Seminar on “Statistical Process Control for Process Development and Validation” at Philadelphia |
| Date de début | 23 Mai 2013 | [ID=547218] |
| Lieu | Philadelphia, États-Unis |
| Résumé | This course will present the procedures that must be used in the application of DOE and SPC to the development, design and monitoring of manufacturing and testing processes. A practical approach with case studies and examples will be used, with theoretical information introduced only when necessary to understand an experiment. Examples from real processes and testing procedures will be used to present the student with examples that will be directly applicable to their work. |
| Sujets | Statistical Process Control, US Seminars, US Conference, Conferences and Seminars, Compliance Training, Philadelphia Seminars, Process Validation, Steven Kuwahara, GLP Seminar, Good Manufacturing Practices, GMP Conference |
| Page web | http://bit.ly/10oxfwt |
| Contact | Event Coordinator; Tél.: [8004479407]; Email.: support@globalcompliancepanel.com |
| | |
| 9.7th Annual Licensing in Generics Forum |
| Dates | 23 Mai 2013 → 24 Mai 2013 | [ID=535909] |
| Lieu | Francfort, Allemagne |
| Sujets | patent laws, compulsory licenses, health care spending, Commercial Operations and Sales |
| Page web | http://pharma.flemingeurope.com/licensing-generics |
| Contact | Andrea Weber; Tél.: [(+421 257 272 335)]; Email.: andrea.weber@flemingeurope.com |
| | |
| 10.Molecular Medicine Tri-Conference Asia |
| Dates | 28 Mai 2013 → 31 Mai 2013 | [ID=542737] |
| Lieu | Singapore, Singapour |
| Résumé | Molecular Medicine Tri-Conference Asia will present three focused conferences presenting the most significant advances in research and technology in the areas of antibody engineering, clinical trial management and molecular diagnostics. |
| Sujets | Singapore, biotech, pharma, biotechnology, Asia, antibody engineering, antibody, clinical data management, clinical data, eClinical trials, eClinical, molecular diagnostics, diagnostics, molecular medicine, drug discovery |
| Page web | http://www.triconferenceasia.com |
| Contact | Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com |
| | |
| 11.CBPF — ChinaBio Partnering Forum 2013 |
| Dates | 29 Mai 2013 → 30 Mai 2013 | [ID=513764] |
| Lieu | Pékin, Chine |
| Résumé | ChinaBio® Partnering Forum 2012 had more than 700 delegates from 400 companies and 22 countries, making it the largest partnering conference in China. The 2013 edition promises to be even better with top notch attendance from pharma and biotech companies as well as leading researchers from China's top universities and institutes. |
| Sujets | partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, China, life science |
| Page web | http://www.ebdgroup.com/cbpf/ |
| Contact | Tél.: [+1 760-930-0500]; Email.: tgunnink@ebdgroup.com |
| Sujets apparentés | Biotechnologie |
| | |
| 12.Nutraceuticals World Asia 2013 |
| Dates | 03 Jui 2013 → 06 Jui 2013 | [ID=511890] |
| Lieu | Singapore, Singapour |
| Résumé | Nutraceuticals World Asia is the region’s leading nutraceuticals event that brings together pharmas, biotechs, food manufacturers and solution providers to discuss innovations, investment, commercialisation, applications and licensing in the nutraceuticals industry in Asia. Hear from senior level executives over 4 days from 3-6 June 2013, packed with conferences and exhibition showcase that highlights the latest innovations and opportunities in the nutraceuticals' space! |
| Sujets | Nutrition, Pharmasceutical, biotechs, food manufacturers |
| Page web | http://www.terrapinn.com/conference/nutraceuticals-world-asia/index.stm |
| Contact | Jolene Lee; Tél.: [63222318]; Email.: jolene.lee@terrapinn.com |
| Sujets apparentés | Chimie alimentaire et agronomie |
| | |
| 13.Drug Discovery & Therapy World Congress 2013 |
| Dates | 03 Jui 2013 → 06 Jui 2013 | [ID=510806] |
| Lieu | Boston, États-Unis |
| Résumé | This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about important international breakthrough developments in drug discovery and on new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. |
| Sujets | drug discovery, drug therapy and translational medicine, new therapeutics. |
| Page web | http://www.ddtwc.com/index.php |
| Contact | Email.: marketing@ddtwc.com |
| | |
| 14.Clinical Trial Oversight Summit |
| Dates | 03 Jui 2013 → 06 Jui 2013 | [ID=532305] |
| Lieu | Boston, MA, États-Unis |
| Résumé | Barnett International and Cambridge Healthtech Institute's second annual Clinical Trial Oversight Summit will feature four co-located conferences covering best practices and recent trends relevant to clinical research monitoring, auditing, clinical quality assurance, site management, and vendor oversight. This four-day summit will include presentations from experts, case studies, interactive breakout discussion groups, workshops, and networking opportunities. Themes throughout will include risk-based approaches to clinical trial management, implementing quality systems-based approaches to GCP compliance, ensuring reliable study data, responding to the evolving regulatory landscape, and preparing sites and clinical research partners for inspection-readiness. |
| Sujets | clinical trials, research, GCP, data |
| Page web | http://www.clinicaltrialsummit.com |
| Contact | Kris Waterman; Email.: kwaterman@healthtech.com |
| Sujets apparentés | Médecine (en général) |
| | |
| 15.WPC — 12th Annual World Pharma Congress |
| Dates | 04 Jui 2013 → 06 Jui 2013 | [ID=539648] |
| Lieu | Philadelphia, PA, États-Unis |
| Résumé | After a dozen years covering various topics for the pharmaceutical industry, the World Pharma Congress has found its niche in effectively covering the latest preclinical strategies and technologies for driving better predictions. Building on its experience covering drug targets, high-throughput screening, lead optimization, ADME and drug safety, the event is now primed to move further downstream into early formulations and drug delivery. |
| Sujets | pharma, drug delivery, life science, conference, drug safety, cancer, oncology, preclinical, pain, therapeutics, imaging, animal model |
| Page web | http://www.worldpharmacongress.com |
| Contact | Kris Waterman; Tél.: [781-972-5400]; Email.: kwaterman@healthtech.com |
| | |
| 16.Mastering Biofilm Control, Monitoring, Validation and Excursion Investigations of Pharmaceutical Water Systems — 2-day In-person Seminar on “Mastering Biofilm Control, Monitoring, Validation and Excursion Investigations of Pharmaceutical Water Systems” at Anaheim |
| Dates | 06 Jui 2013 → 07 Jui 2013 | [ID=548288] |
| Lieu | Anaheim, États-Unis |
| Résumé | This course is designed to provide a microbiology-focused education about all aspects of water systems and how Biofilm manages to thrive there. Prior microbiological education or training, though a plus, is not necessary. The instructor can provide the background needed to understand this very important subject matter. This understanding is essential for the proper design, validation, operation, monitoring, and maintenance of a high purity water system. Without this understanding, water system design and control are merely managed by a set of rules that often don't work and can cause very costly system downtime or even product recalls. |
| Sujets | US Seminars, US Conference , 2013 Pharma Seminar Mastering Biofilm Control, Pharmaceutical Water Systems, USP, Conferences and Seminars, San Francisco Seminar, Compliance Training, microbial test, computer system validation, pharma validation, usp water testing, Pharma validation training |
| Page web | http://bit.ly/15BsuC2 |
| Contact | Tél.: [8004259407]; Email.: support@globalcompliancepanel.com |
| | |
| 17.ESC Working Group - New Trends in Cardiovascular Drug Therapy |
| Dates | 07 Jui 2013 → 08 Jui 2013 | [ID=542688] |
| Lieu | Rome, Italie |
| Résumé | This first meeting of the European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology and Drug Therapy will take place in Rome in June. The congress offers a unique opportunity to engage in interactive sessions with key international speakers and nucleus members. |
| Sujets | Cardio, Drug, Cardiovasculay, Pharmacotherapy, European Society, statins, diabetes, pharmacology, atrial fibrillation, stroke, heart failure, anticoagulants, coronary, heart |
| Page web | http://www.escwg2013.org |
| Contact | Robert Rogers; Tél.: [+39 02 8951 8895]; Email.: escwg@micom.it |
| Sujets apparentés | Cardiologie |
| | |
| 18.Radiopharmaceutical Sciences |
| Dates | 09 Jui 2013 → 14 Jui 2013 | [ID=497605] |
| Lieu | Jeju, Corée du Sud |
| Organisateur | Gordon Research Conference |
| Page web | http://www.grc.org/programs.aspx?year=2013&program=nuchem |
| | |
| 19.GMP Auditor Training for Quality Systems |
| Dates | 11 Jui 2013 → 12 Jui 2013 | [ID=543365] |
| Lieu | Amsterdam, Pays-Bas |
| Résumé | Participants will learn about the key techniques and thought processes which may be used by auditors to maximize the benefits of each type of audit. These include planning and preparation, the audit team, structuring the audit, close out, CAPAs and follow up. |
| Page web | http://www.pharma-training-courses.com/gmp-auditor-training-for-quality-systems_1.htm |
| Contact | Judy Callanan; Tél.: [0044 2071937703]; Email.: info@pharma-training-courses.com |
| | |
| 20.Tablet Process Development, Validation and the application of QbD |
| Dates | 12 Jui 2013 → 14 Jui 2013 | [ID=543427] |
| Lieu | Beckenham, near London, Royaume-Uni |
| Résumé | This interactive workshop provides up-to-date, relevant and detailed information on the impact of Quality by Design (QbD) on the Development and Validation of tablet manufacturing processes. It will also study the identification and evaluation of Critical Product Attributes and Critical Process Parameters for tablets, and their implications for process control. We develop new concepts including the use of risk and process matrices for risk management. The latest ICH and FDA guidance on Quality by Design and Process Development, published in 2009, will be comprehensively reviewed. |
| Sujets | QbD, Quality by Design, Pharmaceutical Regulatory, Process Development, Tablet Formulation, mixing, granulation |
| Page web | http://www.pharma-training-courses.com/tablet-process-development-validation-and-the-application-of-qbd_7.htm |
| Contact | Judy Callanan; Tél.: [0044 2071937703]; Email.: info@pharma-training-courses.com |
| | |
| 21.HPLC Analytical Method Development and Validation |
| Dates | 13 Jui 2013 → 14 Jui 2013 | [ID=544492] |
| Lieu | Londres, Royaume-Uni |
| Résumé | This course provides a comprehensive coverage of the method development and validation requirements that are essential to progress a pharmaceutical compound, at each stage of product development.
Upon completion of this course, delegates will have learned what is necessary to develop and validate methods for drug substance and drug product to comply with international regulatory guidelines.
Who Should Attend?
Scientists working with HPLC who need to further their understanding of the technique in order to develop better methods faster. Scientists who have to validate HPLC methods in accordance with current internationally-accepted guidance. HPLC technicians working in R&D laboratories, quality control laboratories and stability testing laboratories.
Managers with a responsibility for generating regulatory submissions. |
| Sujets | Analytical Development, Analytical Chemistry, Stability Testing, Formulation Development, Regulatory Affairs, Product Development, HPLC separation mode, Stability-indicating methods, Validation of chromatographic methods, |
| Page web | http://www.pharma-training-courses.com/hplc-analytical-method-development-and-validation_13.htm |
| Contact | Judy Callanan; Tél.: [++44 20 71937703]; Email.: info@pharma-training-courses.com |
| | |
| 22.HPLC Analytical Method Development and Validation |
| Dates | 13 Jui 2013 → 14 Jui 2013 | [ID=543331] |
| Lieu | Amsterdam, Pays-Bas |
| Résumé | Analytical methods must be validated to provide reliable data for regulatory submissions. These methods are essential for a number of purposes, including testing for QC release, testing of stability samples, testing of reference materials and to provide data to support specifications. This course provides a comprehensive coverage of the method development and validation requirements that are essential to progress a pharmaceutical compound, at each stage of product development. |
| Sujets | HPLC, Analytical Development, Method Validation, validation of Chromotographic Methods |
| Page web | http://www.pharma-training-courses.com/hplc-analytical-method-development-and-validation_13.htm |
| Contact | Judy Callanan; Tél.: [0044 2071937703]; Email.: info@pharma-training-courses.com |
| Sujets apparentés | Formation en chromatographie (GC, HPLC, UPLC) |
| | |
| 23.HIV Drug Therapy in the Americas |
| Dates | 13 Jui 2013 → 15 Jui 2013 | [ID=536666] |
| Lieu | Sao Paulo, Brésil |
| Résumé | This 3-day scientific meeting will build upon the Glasgow UK HIV Drug Therapy meeting heritage to establish an accessible and regionally relevant programme focusing on a range of issues relating to HIV treatment. A truly global faculty will meet in São Paulo to discuss, during plenaries and case-based presentations, topics of real interest to those working within the ‘Americas’ region. Abstract presentations will, like Glasgow, promote audience participation and discussion. |
| Sujets | HIV, Prevention, MTCT, HAART, ART |
| Page web | http://www.hivamericas.org |
| Contact | Tél.: [01625644127]; Email.: hivamericas@kp360group.com |
| Sujets apparentés | Médecine (en général) |
| | |
| 24.Next-Gen Kinase Inhibitors |
| Dates | 17 Jui 2013 → 19 Jui 2013 | [ID=532304] |
| Lieu | Boston, MA, États-Unis |
| Résumé | This established and well recognized kinase conference addresses re-occurring questions about selectivity, safety, resistance and novelty. After many years of research and therapeutic developments of kinase inhibitors, the field still offers new opportunities as novel kinases and their inhibitors are making an appearance. In addition, interest in the repurposing of already developed drugs is growing immensely. |
| Sujets | kinase, drug development, pharmaceutical, therapeutic |
| Page web | http://www.healthtech.com/KIN |
| Contact | Kris Waterman; Email.: kwaterman@healthtech.com |
| | |
| 25.World Vaccine Congress Asia 2013 |
| Dates | 17 Jui 2013 → 20 Jui 2013 | [ID=511915] |
| Lieu | Singapore, Singapour |
| Résumé | Back for the 7th year next year, World Vaccine Congress brings together all the major vaccine stakeholders, through pharmas, biotechs, NGOs, research institutes, regulators and CDCs to discuss latest industry trends, business strategies and scientific developments in the global and Asian vaccine markets. In 2012, we hosted over 300 attendees and featuring over 80 world class speakers from the vaccine industry, the conference has once again, demonstrated that IT IS THE vaccine industry platform in Asia for serious business networking and learning. |
| Sujets | Vaccine, Health, Medicine |
| Page web | http://www.terrapinn.com/2013/world-vaccines-congress-asia/index.stm |
| Contact | Jolene Lee; Tél.: [63222318]; Email.: jolene.lee@terrapinn.com |
| | |
| 26.Asia Antibody Congress 2013 |
| Dates | 17 Jui 2013 → 20 Jui 2013 | [ID=511947] |
| Lieu | Singapore, Singapour |
| Résumé | Antibody Congress Asia will serve as a platform for pharmas, biotechs, research institutes and solution providers to discuss business development, scientific advancement and partnerships for their antibody business. Showcasing major global trends, recent intra-market clinical progress, best practice and 1-2-1 partnering opportunities, this event delivers unrivalled industry participation across the antibody value chain. |
| Sujets | Biotechs, Pharmas, Health, Antibody |
| Page web | http://www.terrapinn.com/conference/asia-antibody-congress/index.stm |
| Contact | Jolene Lee; Tél.: [63222318]; Email.: jolene.lee@terrapinn.com |
| | |
| 27.World Orphan Drugs Congress Asia 2013 |
| Dates | 18 Jui 2013 → 19 Jui 2013 | [ID=542757] |
| Lieu | Singapore, Singapour |
| Résumé | World Orphan Drug Congress Asia 2013 is Asia's largest global orphan drug industry event. This event is dedicated to fostering partnerships and collaboration amongst industry, governments, payers, investors and patients. |
| Page web | http://www.terrapinn.com/conference/world-orphan-drugs-congress-asia/ |
| | |
| 28.Structure-Based Drug Design |
| Dates | 19 Jui 2013 → 21 Jui 2013 | [ID=532325] |
| Lieu | Boston, MA, États-Unis |
| Résumé | The 13th Structure-Based Drug Design conference will feature the development of in silico technology as well as experimental approaches useful for accurately predicting and modeling the structures of proteins in structure-based drug design efforts. In addition, examples of successful applications of such technology approaches to genome-to-drug lead investigations are showcased. |
| Sujets | pharmaceutical, drug design, GPCR, therapeutic, drug discovery, epigenetics, genome |
| Page web | http://www.healthtech.com/SBD |
| Contact | Kris Waterman; Email.: kwaterman@healthtech.com |
| Sujets apparentés | Modélisation moléculaire |
| | |
| 29.QbD and Lifecycle Management for Analytical Methods |
| Dates | 20 Jui 2013 → 21 Jui 2013 | [ID=544537] |
| Lieu | Londres, Royaume-Uni |
| Résumé | A QbD and lifecycle management approach to analytical method development and qualification will result in a better understanding and fewer failures of analytical methods due to more robust methods which produce consistent, reliable, quality data throughout the lifecycle. This, in turn, will lead to less method transfer failures, OOS results and method "incidents" when used in the routine environment. As the industry is now applying Quality by Design (QbD) to process development, it is now being recognized that this is also the way forward to improve and standardise our approach to analytical procedures.
This two day training course presents a brief overview of method validation according to ICHQ2 (R1) and discusses the limitations of this approach in terms of its contribution to failure of methods with regards to method transfer and generation of OOS results later in the method lifecycle. It then illustrates that the lifecycle approach is a holistic process which embraces the philosophies of the traditional approach but results in more robust analytical procedures. Finally a comparison of the current approach (ICHQ2) and the QbD approach is presented.
The course focuses on HPLC methods; therefore experience in developing, validating and transferring analytical HPLC methods would be an advantage to participants.
The material is presented by means of slides, handouts and participation of the attendees through discussion, case studies and hands on group exercises.
Overview:
This course is designed to provide training in how to apply Quality by Design and lifecycle management to the development and qualification of analytical methods. It aims to highlight the limitations of the current approach to method validation (ICHQ2) and the benefits to using the QbD approach. Although the QbD and Lifecycle management approach is not yet officially recognised for analytical methods, the course is based on the approach used for manufacturing processes and products as described in ICH Q8, Q9 and Q10. |
| Sujets | Quality by Design, QbD, lifecycle approach to analytical methods, Applying the QbD and lifecycle approach to development and qualification of analytical methods, controlling variables of analytical methods, QbD and lifecycle management approach to analytical methods, Define an Analytical Target Profile, importance of understanding method variables of individual methods, Develop more robust analytical methods |
| Page web | http://www.pharma-training-courses.com/qbd-and-lifecycle-management-for-analytical-methods_35.htm |
| Contact | Judy Callanan; Tél.: [++44 20 71937703]; Email.: info@pharma-training-courses.com |
| | |
| 30.RNAi Conference — 4th RNAi Research & Therapeutics Conference |
| Dates | 20 Jui 2013 → 21 Jui 2013 | [ID=540648] |
| Lieu | San Francisco, États-Unis |
| Résumé | GTC is proud to once again bring together the leading experts across industry and academia to meet, discuss and exchange their findings on RNAi and advances in delivery, therapeutics, technology and other applications. Join us as we talk more in-depth about current hot topics in the field such as miRNA, non-coding RNA, gene-editing and CRISPRs and many more. |
| Sujets | Antisense, MicroRNA, MicroRNA, ncRNA, ncRNA, Oligonucleotides, RNA Interference, RNAi, long non-coding RNAi |
| Page web | http://www.gtcbio.com/component/conference/?file=home&cn=4th+RNAi+Research+&Therapeutics=&cid=32&utm_source=portalwebsite&utm_medium=website&utm_content=event%2Boverview&utm_campaign=RNAi%2BPosting |
| Contact | Tél.: [6262566405]; Email.: infogtcbio@gtcbio.com |
| Sujets apparentés | Biologie moléculaire; Biotechnologie |
| | |
| 31.EFGCP Workshop on 'A Practical Approach to Risk-Based Monitoring' |
| Date de début | 24 Jui 2013 | [ID=536302] |
| Lieu | Londres, Royaume-Uni |
| Résumé | The Education Working party is currently developing materials on risk-based monitoring. This potentially flexible approach to monitoring is possible especially with the use of current technologies but many have been reluctant to follow this route. It was recognised early in EFGCP’s process of developing risk-based training that despite all the discussions about adaptive monitoring, how clinical researchers should develop this approach at a practical level is less easy to understand. This new approach needs to ensure that subjects are protected on clinical trials and that data quality is not compromised. The aim of the Workshop is to interact directly with the regulators and other interested groups in order to discuss what can realistically be achieved and to define when researchers still need to follow more traditional approaches. |
| Sujets | Education, training, GCP, clinical, trials, medical, scientific, education, regulatory authorities, risk-based, monitoring, risk management, quality, regulation, EFGCP, researchers, technology, data quality, workshop |
| Page web | http://www.efgcp.be/Events.asp?TimeRef=1&Type=1&L1=10&L2=1&L3=1 |
| Contact | Tél.: [+32 2 732 87 83]; Email.: conferences@efgcp.eu |
| | |
| 32.ICR — 11th Annual Ion Channel Retreat |
| Dates | 24 Jui 2013 → 26 Jui 2013 | [ID=537589] |
| Lieu | Vancouver, Canada |
| Résumé | In June 2013, Aurora Biomed will be hosting the 11th Annual Ion Channel Retreat in Vancouver, Canada. Each year, researchers use this forum to discuss and debate a spectrum of topics from ion channel research and technology to drug discovery and safety. Topics at this year’s Retreat will include Ion Channels as Disease Targets, Ion Channel Structure and Function, Ion Channel Screening Technologies and Cardiac Function and Pharmacology – just to name a few. |
| Sujets | Ion Channel Drug discovery Disease Targets Pharmacology Screening Technologies |
| Page web | http://www.aurorabiomed.com/ion-channel-retreat-2013.htm |
| Contact | Ashley; Tél.: [1-604-215-8700]; Email.: retreat@aurorabiomed.com |
| Sujets apparentés | Biologie moléculaire |
| | |
| 33.IWPCPS-15 - International Workshop on Physical Characterization of Pharmaceutical Solids |
| Dates | 24 Jui 2013 → 27 Jui 2013 | [ID=549789] |
| Lieu | Philadelphia, États-Unis |
| Organisateur | assa Inc. |
| Page web | http://www.assainternational.com |
| Sujets apparentés | Chimie de la matière condensée |
| | |
| 34.Streamlined Organic Synthesis: Practical Catalysis |
| Dates | 25 Jui 2013 → 27 Jui 2013 | [ID=550083] |
| Lieu | Barcelona, Espagne |
| Organisateur | Scientific Update LLP |
| Page web | http://www.scientificupdate.co.uk/conferences/conferences-schedule.html |
| | |
| 35.Technology Transfer |
| Dates | 26 Jui 2013 → 28 Jui 2013 | [ID=544538] |
| Lieu | Londres, Royaume-Uni |
| Résumé | This three-day interactive workshop is intended to provide an overview of the challenges that must be overcome in transferring manufacturing technology and to highlight some proven techniques for overcoming those challenges.
The focus of the course is on small-molecules and their formulations rather than biological products, although many of the issues faced and techniques discussed will be equally applicable.
Some of the benefits to be derived from this workshop include:
* An appreciation of where TT fits in the life cycle of a pharmaceutical product.
* An appreciation of the importance of planning and project management in TT.
* An overview of the potential complexity of technology and product transfer.
* An outline of proven best practice in technology transfer.
* An opportunity to discuss current issues and challenges in technology transfer with peers and with an expert faculty.
* A consideration of 'where next' as we move from traditionally-developed products to a world where products are developed using QbD techniques and controlled by PAT.
Who Should Attend?
Pharmaceutical technologists, Quality Assurance staff, Regulatory staff, Engineering staff, Project Managers and anybody else involved in the transfer of products or technology from one location to another. |
| Sujets | Pharmaceutical Product Lifecycle, Product Transfer, Technology Transfer |
| Page web | http://www.pharma-training-courses.com/technology-transfer-_14.htm |
| Contact | Judy Callanan; Tél.: [++44 20 71937703]; Email.: info@pharma-training-courses.com |
| | |
| 36.Technology Transfer |
| Dates | 26 Jui 2013 → 28 Aou 2013 | [ID=543417] |
| Lieu | Londres, Royaume-Uni |
| Résumé | The focus of the course is on small-molecules and their formulations rather than biological products, although many of the issues faced and techniques discussed will be equally applicable. |
| Sujets | QbD, Quality by Design, Pharmaceutical Technology Transfer, Pharmaceutical Regulatory, Pharmaceutical Quality |
| Page web | http://www.pharma-training-courses.com/technology-transfer-_14.htm |
| Contact | Judy Callanan; Tél.: [0044 2071937703]; Email.: info@pharma-training-courses.com |
| | |
| 37.GPM Summit — 8th Annual Global Pharma Manufacturing Summit 2013 |
| Dates | 27 Jui 2013 → 28 Jui 2013 | [ID=524060] |
| Lieu | Boston, États-Unis |
| Résumé | The Global Pharma Manufacturing summit is one of North America's leading annual events, attracting over 150 senior manufacturing professionals to discuss the current challenges, develop improved manufacturing strategies and analyze the latest case studies. |
| Sujets | pharma manufacturing, small and large molecule |
| Page web | http://www.gpmsummit.com |
| Contact | Sema Tezel ; Tél.: [+1 416 214 1144]; Email.: enquire@wtgevents.com |
| | |
| 38.ISCP — 18th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacology |
| Dates | 28 Jui 2013 → 30 Jui 2013 | [ID=542665] |
| Lieu | Rome, Italie |
| Résumé | We are delighted to invite you to join us in Rome from 28th to 30th June 2013 on the occasion of the 18th Annual Scientific Meeting of the ISCP. The scientific sessions of ISCP will once again be focused on advances in cardiovascular pharmacotherapy and we have produced a very interactive programme to give the audience ample time to interact with the members of the Faculty both during the lectures and poster sessions. |
| Sujets | Cardio, Drug, Cardiovasculay, Pharmacotherapy, European Society, statins, diabetes, pharmacology, atrial fibrillation, stroke, heart failure, anticoagulants, coronary, heart, |
| Page web | http://www.iscp2013.com |
| Contact | Robert Rogers; Tél.: [+39 02 8951 8895]; Email.: iscp@micom.it |
| Sujets apparentés | Cardiologie |
| | |
| 39.Pharmacokinetics in Drug Development - for non-specialists |
| Dates | 01 Jul 2013 → 02 Jul 2013 | [ID=543459] |
| Lieu | Londres, Royaume-Uni |
| Résumé | To provide participants with an overview of the principles of Pharmacokinetics and Pharmacokinetic/Pharmacodynamic modelling and how, together with regulatory guidances, they can be used to effectively deliver drug development programmes. |
| Sujets | Clinical Research, Pharmaceutical Regulatory, Pharmacokinetics, Pharmacodynamics. Drug Development. Regulatory affairs |
| Page web | http://www.pharma-training-courses.com/pharmacokinetics-in-drug-development---an-integrated-approach_12.htm |
| Contact | Judy Callanan; Tél.: [0044 2071937703]; Email.: info@pharma-training-courses.com |
| | |
| 40.Pharmaceutical Packaging - an introductory course |
| Date de début | 02 Jul 2013 | [ID=543403] |
| Lieu | Londres, Royaume-Uni |
| Résumé | Pharmaceutical Packaging is a very specialised area with its own unique issues and problems. This one day course will provide delegates with a good basic grounding and appreciation of what is required for the packaging of pharmaceutical and healthcare products. Whether you know nothing, have a basic understanding or are familiar with the area, this course will provide you with the useful knowledge and insights from an expert who has worked in the industry for over 20 years. |
| Page web | http://www.pharma-training-courses.com/pharmaceutical-packaging---an-introductory-course-_19.htm |
| Contact | Judy Callanan; Tél.: [0044 2071937703]; Email.: info@pharma-training-courses.com |
| | |
| 41.RICT 2013 - Discovery and Selection - When Chemical Biology meets Drug Design |
| Dates | 03 Jul 2013 → 05 Jul 2013 | [ID=550128] |
| Lieu | Nice, France |
| Organisateur | European Federation for Medicinal Chemistry (EFMC) and ChemBridge Corporation |
| Page web | http://www.rict2013.org |
| Sujets apparentés | Biochimie et chimie médicale |
| | |
| 42.8PKDD — 8th Protein Kinases in Drug Discovery Conference |
| Dates | 08 Jul 2013 → 09 Jul 2013 | [ID=542417] |
| Lieu | Boston, États-Unis |
| Résumé | Despite the hundreds of kinase inhibitors currently in discovery and pre-clinical phases, the number of kinase inhibitors which have been approved and are on the market remains low by comparison. This discrepancy reflects the challenges which accompany the development of ATP-competitive kinase inhibitors, including low specificity and off-target binding. There is also the problem of gatekeeper-associated drug resistance. To remain competitive in the kinase field, it will require you to stay abreast with recent development trends and technological advancements aimed at circumventing these issues. We will also provide you with a broad overview of the role kinases play in various types of cancer as well as introduce you to several novel kinases and inhibitor candidates. |
| Sujets | activator proteins , AGC kinases, ALK, allosteric inhibitors, allosteric kinase, anti-mitotic therapies, antitumor agent, automated cellular profiling, autophosphorylation, biacore, binding kinetics, bi-specific drugs |
| Page web | http://www.gtcbio.com/component/conference/?file=home&cn=8th+Protein+Kinases+in+Drug+Discovery&cid=24&utm_source=3rdparty&utm_medium=eventlisting&utm_campaign=8pkdd |
| Contact | Kristen Starkey; Tél.: [6262566405]; Email.: infogtcbio@gtcbio.com |
| Sujets apparentés | Biotechnologie |
| | |
| 43.11th Vaccines Research and Development: All Things Considered |
| Dates | 08 Jul 2013 → 10 Jul 2013 | [ID=537500] |
| Lieu | Boston, États-Unis |
| Résumé | Development of new vaccines truly requires a consideration of many things. We examine vaccine development from basic research to marketing. We bring together the people who make the discoveries, make the decisions, fund the work and license the vaccines and foster their interaction with the attendees to share their perspectives of the vaccine industry. The latest information on the new malaria, HIV, tumor, and therapeutic vaccines, DNA vaccines, adjuvants, mucosal and other delivery mechanisms will be presented, as will updates on governmental priorities, funding, and the FDA. Representatives from the HHS, BARDA and NIH as well as NGO will provide a first-hand perspective into current US vaccines policy, regulation and funding as well as updates on the pandemic and bio-defense policy. All aspects from discovery to marketing will be covered. |
| Page web | http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=11th Vaccines Research and Development: All Things Considered&cid=48 |
| Contact | Tél.: [6262566405]; Email.: infogtcbio@gtcbio.com |
| | |
| 44.10th Anti-infectives Partnering and Deal-Making Conference |
| Dates | 08 Jul 2013 → 10 Jul 2013 | [ID=541763] |
| Lieu | Boston, États-Unis |
| Résumé | GTC's 10th Anti-infectives Partnering and Deal-Making Conference, taking place on July 8-10, 2013 in Boston, MA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases. The agenda also allows time for networking and opportunities to interface with speakers and fellow delegates in a collegial setting. Previous GTC conferences have been catalytic to several successful partnerships and in 2013 we expect this trend to continue. |
| Sujets | anti-infectives |
| Page web | http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=10th Anti-Infectives Partnering and Deal-making&cid=41 |
| Contact | Eileen Zhao; Tél.: [6262566405]; Email.: infogtcbio@gtcbio.com |
| | |
| 45.Pharma Trials Korea 2013 |
| Dates | 08 Jul 2013 → 11 Jul 2013 | [ID=511913] |
| Lieu | Korea, Corée du Sud |
| Résumé | Pharma Trials World Korea 2013 is where pharma companies, trial sponsors, regional and international CROs and clinical trial sites gather to strategise in accelerating clinical development, accessing emerging markets, enhancing clinical operations through effective offshoring and outsourcing in Korea.Join senior level attendees from international pharmas looking to obtain regulatory data for products in Korea, to regional companies trying to optimize drug clinical development. Tap into the Korea's pharma markets by partnering with CROs and clinical trial sites. |
| Sujets | Pharma, Clinical, pharma |
| Page web | http://www.terrapinn.com/conference/pharma-trials-world-korea/ |
| Contact | Jolene Lee; Tél.: [63222318]; Email.: jolene.lee@terrapinn.com |
| | |
| 46.Partnering for Global Impact® 2013 |
| Dates | 10 Jul 2013 → 11 Jul 2013 | [ID=532510] |
| Lieu | Lugano, Suisse |
| Résumé | EuroMedtech™ is the annual medical technology conference that provides collaboration opportunities to medtech CEOs, large corporation business development executives, investors and service providers. |
| Page web | http://www.pfgi.com |
| Contact | Tél.: [1-760-930-0500]; Email.: conferences@ebdgroup.com |
| Sujets apparentés | Physique appliquée: Biophysique et génie biomédical |
| | |
| 47.CAPA – The Heart of Your Quality System |
| Date de début | 11 Jul 2013 | [ID=549642] |
| Lieu | Texas, Houston, États-Unis |
| Organisateur | Compliance2go |
| Page web | https://compliance2go.com/index.php?option=com_training&speakerkey=46&productKey=246 |
| | |
| 48.4th International Conference on Biomarkers and Clinical Research |
| Dates | 15 Jul 2013 → 17 Jul 2013 | [ID=549955] |
| Lieu | Philadelphia, États-Unis |
| Organisateur | OMICS Group |
| Page web | http://www.omicsgroup.com/conferences/biomarkers-2013/venue.php |
| | |
| 49.4th International Congress on Biomarkers & Clinical Research |
| Dates | 16 Jul 2013 → 17 Jul 2013 | [ID=512741] |
| Lieu | Philadelphia, Pennsylvania, États-Unis |
| Page web | http://www.omicsgroup.com/conferences/biomarkers-clinical-research-2013/ |
| Sujets apparentés | Médecine (en général) |
| | |
| 50.The Future of Off-Label Marketing After the Caronia Decision |
| Date de début | 18 Jul 2013 | [ID=549630] |
| Lieu | Houston, Texas, États-Unis |
| Organisateur | Compliance2go |
| Page web | https://compliance2go.com/index.php?option=com_training&speakerkey=50&productKey=237 |
| | |
| 51.MRIC 2013 — Redox Modulation of Health and Disease: From Inorganic Chemistry to Translational Medicine |
| Dates | 20 Jul 2013 → 22 Jul 2013 | [ID=530974] |
| Lieu | Erlangen, Allemagne |
| Résumé | Increased challenges in health care urgently call for the development and exploitation of less conventional, redox active molecules that meet the biomedical requirements of the time ahead of us. Chronic inflammation, pain and accelerated ageing are important problems in many autoimmune, inflammatory and neurodegenerative diseases. This conference will focus on latest developments of redox active metal-based compounds as therapeutics as well as diagnostic and bio-imaging tools. Special focus will be on modulation of cellular signaling by redox active inorganic molecules and their (patho)physiological consequences. The interplay of gasotransmitters (NO and hydrogen sulfide) and subsequent changes of cellular signaling as potential targets for cell rescuing will be discussed. |
| Sujets | Redox Active Metal Based Therapeutics, Chemical Tools for Molecular Imaging, Molecular Mechanisms of Inflammation and Neurodegeneration, Reversible Posttranslational Modifications of Thiols, Signaling via Gasotransmitters |
| Page web | http://www.chemie.uni-erlangen.de/mric-conference/information/home |
| Sujets apparentés | Biochimie et chimie médicale |
| | |
| 52.Creating a compliant Internal Auditing system |
| Date de début | 25 Jul 2013 | [ID=549728] |
| Lieu | Texas, Houston, États-Unis |
| Organisateur | Compliance2go |
| Page web | https://compliance2go.com/index.php?option=com_training&speakerkey=64&productKey=256 |
| | |
| 53.Vaccines-2013 — 3rd International Conference On vaccines & vaccinations |
| Dates | 29 Jul 2013 → 31 Jul 2013 | [ID=520897] |
| Lieu | Las Vegas, États-Unis |
| Résumé | Vaccines-2013 is a scientific platform to meet fellow key decision makers all-around the academic institutions, healthcare institutes, pharmaceutical, biotech, CROs, vaccine developers supply chain, logistics practitioners making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies in Vaccines & Vaccination, making the Congress a perfect platform to share proficiency. |
| Sujets | Immune System, B and T Cells, Cellular and Molecular-Based Vaccines, Vaccines against Infectious Diseases, Manufacturing, Production, and Development of Vaccines, Regulatory and Ethical Issues of Vaccines and Public Acceptance, Current Issues on Clinical Evaluation and Field Trials of Vaccines, Modern Technologies in Vaccine Discovery and Development, Age-specific Immune Response to Vaccination. |
| Page web | http://www.omicsgroup.com/conferences/vaccines-vaccination-2013/ |
| Contact | Tél.: [+1-650-268-9744, 1-800-216-6499]; Email.: vaccines2013@omicsgroup.com |
| Sujets apparentés | Médecine (en général) |
| | |
| 54.2nd International Conference on Translational Medicine |
| Dates | 05 Aou 2013 → 07 Aou 2013 | [ID=522982] |
| Lieu | Chicago, États-Unis |
| Résumé | Translational Medicine-2013 will cover current and emerging challenges in the biopharmaceutical industry and strategies for drug development. Current strategies and processes for drug discovery and development within the pharmaceutical industry are contrasted with the adoption of Translational Medicine research strategies. Translational Medicine-2013 considers the requirements of various medical advances in terms of innovative strategic approaches to deliver advances to patients, and the contrasting requirements for effective translation in commercial companies and health services. It will cover integration across scientific, medical and socio-economic disciplines. |
| Sujets | Molecular Biology in Translational Research, Biomarkers in Translational Medicine, Pharmaco Genomic Testing in Current Clinical Practice, Diseases Treated with Targeted Molecular Therapy, Translational Modeling of Efficacy & Safety, Clinical Epidemiology, Translation of Animal Models to the Clinic, Tumor Biobanks in Translational Medicine, Advances in Translational Medicine. |
| Page web | http://www.omicsgroup.com/conferences/translational-medicine-2013/index.php |
| Contact | Katherine OMICS Group Conferences 5716 Corsa Ave¦Suite110 Westlake, Los Angeles CA-91362-7354, USA Email: translationalmedicine2013@omicsgroup.com Office: +1- 650-268-9744 Toll Free: +1-800-216-6499(USA & Canada) Fax: +1-650-618-1414; Email.: translationalmedicine2013@omicsgroup.com |
| | |
| 55.personalizedmedicine2013 — International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics |
| Dates | 05 Aou 2013 → 07 Aou 2013 | [ID=529238] |
| Lieu | Chicago, États-Unis |
| Résumé | Personalized Medicine-2013 scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies in Personalized Medicine. The meeting will put forward the tradition of bringing together different communities and contributing to an integrative approach to Personalized Medicine Research across all scales of observation. |
| Sujets | Current Focus of Personalized Medicine Personalized Medicine - Reached the Clinic Human Genetic Variation Companion Diagnostics - Adding Value to Personalized Medicine Biomarkers in Personalized Medicine Nanotechnology and Personalized Medicine-Dreams to Market Pharmaceutical Analysis Methods to Develop Personalized Medicine Proteomics Bioengineering in the Field of Personalized Medicine Translational Medicine - Recent Advances Lifestyle Medicine |
| Page web | http://www.omicsgroup.com/conferences/personalized-medicine-molecular-diagnostics-2013/index.php |
| Contact | Tél.: [+1-650-268-9744]; Email.: personalizedmedicine2013@omicsgroup.com |
| Sujets apparentés | Biologie moléculaire |
| | |
| 56.61st International Congress and Annual Meeting of the Society of Medicinal Plant and Natural Product Research |
| Dates | 01 Sep 2013 → 05 Sep 2013 | [ID=514316] |
| Lieu | Münster, Allemagne |
| Organisateur | Webster University |
| Page web | http://www.ga2013.org/ |
| Inscription via COMS | https://www.conference-service.com/ga2013/welcome.cgi |
| | |
| 57.RPS Annual Conference 2013 — Royal Pharmaceutical Society Annual Conference 2013 |
| Dates | 08 Sep 2013 → 09 Sep 2013 | [ID=532198] |
| Lieu | Birmingham, Royaume-Uni |
| Résumé | Our Annual Conference 2013 will be held on Sunday 8 – Monday 9 September, once again at the ICC in Birmingham. The event will be built with our members in mind as we bring you a new look programme featuring key topical issues from across pharmacy that our members tell us are affecting them. We will cover key themes addressing Public Health, Medicines Optimisation and Leadership in a redesigned two day event. |
| Page web | http://www.rpharms.com/rps-annual-conference/rps-conference-2013.asp |
| Contact | Amy Le Vannais; Tél.: [0845 257 2570]; Email.: events@rpharms.com |
| Sujets apparentés | Médecine (en général) |
| | |
| 58.Vaccine Delivery and Stabilization: Improving the Reach of Vaccines |
| Dates | 08 Sep 2013 → 10 Sep 2013 | [ID=541672] |
| Lieu | Boston, États-Unis |
| Résumé | This ECI Conference will address cutting-edge technical and scientific issues in the delivery and stabilization of vaccines. It will aslo provide a forum to discuss broader issues related to vaccine delivery that will be of interest to institutional, industrial and academic participants. The focus of the conference will be to highlight the latest innovations in delivery technologies, devices, stabilization, adjuvant formulations and mechanisms to advance the field of vaccine development. |
| Sujets | delivery technologies devices novel stabilization formulations approaches mechanisms adjuvants vaccines fuels pre-clinical optimization |
| Page web | http://www.engconfintl.org/13ah.html |
| Contact | Tél.: [1-212-514-6760]; Email.: arlene@engconfintl.org |
| | |
| 59.ET-13 — Thirteenth International Conference on Endothelin |
| Dates | 08 Sep 2013 → 11 Sep 2013 | [ID=547290] |
| Lieu | Tokyo, Japon |
| Résumé | The International Conferences on Endothelin are biennial events which represent a unique chance for academic and industrial researchers as well as clinicians from all over the world to share their latest progresses in the science of endothelin. The next edition will be an anniversary meeting since we will be celebrating 25 years of the discovery of endothelin in 1988. |
| Sujets | Endothelin, Endothelin receptor, Pharmacology, Cardiovascular diseases, Clinical Studies, Cancer |
| Page web | http://www.endothelin-2013-tokyo.com/ |
| Sujets apparentés | Biologie; Médecine (en général) |
| | |
| 60.The 5th Annual Personalized Medicine Conference |
| Dates | 11 Sep 2013 → 12 Sep 2013 | [ID=550086] |
| Lieu | Boston, États-Unis |
| Organisateur | Arrowhead Publishers and Conferences |
| Page web | http://www.personalizedmedicinepartnerships.com/ |
| | |
| 61.3rd Annual Pharma eMarketing Congress |
| Dates | 12 Sep 2013 → 13 Sep 2013 | [ID=545699] |
| Lieu | Barcelona, Espagne |
| Sujets | marketing innovations, connecting with customers, social media, multichannel distribution |
| Page web | http://pharma.flemingeurope.com/pharma-emarketing-congress |
| Contact | Andrea Weber; Tél.: [+421 257 272 335]; Email.: andrea.weber@flemingeurope.com |
| | |
| 62.Molecular Diagnostics World Congress |
| Dates | 12 Sep 2013 → 13 Sep 2013 | [ID=519539] |
| Lieu | San Diego, Californie, États-Unis |
| Résumé | There will be particular focus on point-of-care diagnostics, predictive biomarkers and their discovery and detection. Additionally, the cutting-edge subjects of circulating tumour cells and diagnostic applications of exosomes will be explored, giving delegates a brilliant insight into this rapidly expanding field. |
| Sujets | Molecular Diagnostics, Point-of-care Diagnostics, Predictive Biomarkers, Circulating Tumor Cells, Diagnostic Applications of Exosomes |
| Page web | http://selectbiosciences.com/conferences/index.aspx?conf=MDWC2013 |
| Contact | Hannah Tweet; Tél.: [+44 (0) 1787 315124]; Email.: h.tweed@selectbio.com |
| Sujets apparentés | Biotechnologie |
| | |
| 63.2013 PDA FDA Joint Regulatory Conference |
| Dates | 16 Sep 2013 → 18 Sep 2013 | [ID=550045] |
| Lieu | Washington, DC, États-Unis |
| Page web | http://www.pda.org/pdafda2013 |
| | |
| 64.CMC Analytical Comparability Masterclass |
| Dates | 17 Sep 2013 → 18 Sep 2013 | [ID=550527] |
| Lieu | Vienne, Autriche |
| Résumé | Participants will be introduced to state-of-the art analytical methods and concepts. This will include topics such as analytical characterization of biosimilar and reference product, quality target product profile, acceptable range of variability, and justification of differences. Case studies of originator biologics and biosimilar products incl. examples addressing the development of biosimilar monoclonal antibody products will be discussed. At the end of the 2 day Masterclass, the participants will understand the latest regulatory requirements and technical aspects for successful development and analytical comparability / similarity studies. |
| Sujets | Biologics, Biosimilars, Biobetters, protein characterisation |
| Page web | http://pharma.flemingeurope.com/cmc-analytical-compatibility |
| Contact | Andrea Weber; Tél.: [+421 257 272 335]; Email.: andrea.weber@flemingeurope.com |
| | |
| 65.2013 PDA/FDA Workshop on Improving Investigations |
| Dates | 18 Sep 2013 → 19 Sep 2013 | [ID=550058] |
| Lieu | Washington, DC, États-Unis |
| Page web | http://www.pda.org/investigations2013 |
| | |
| 66.Analytics2013 — Advanced Analytics for Therapeutic Proteins: from Research to Manufacturing |
| Dates | 18 Sep 2013 → 20 Sep 2013 | [ID=541863] |
| Lieu | Irsee, Allemagne |
| Résumé | Development and manufacturing of biopharmaceuticals requires highly sophisticated analytics at all stages of the process. These drug development programs are currently facing a higher attrition rate and an increasing regulatory demand to characterize the product and manufacturing process. More recently, the emerging portfolio of biosimilar programs is driving another leap in understanding how the manufacturing process defines product quality. The conference aims to bring researchers from academia and industry together to discuss novel trends in analytical science. It will be focused on all approaches that aim to lower attrition, improve characterization of products and impurities and increase process knowledge and safety. |
| Sujets | Protein Drug Lead Identification, Predictability and Developability - Increasing Technical Success, Bioassays - Molecules in Action, Analysis of Modifications and Conju-gates - ADCs, PEG and more, Analysis of Byproducts; Omics Technologies - Promise and Power; Chip Technologies; Analytics of Trace Elements; Detection of Biological Contami-nants; "Discovery of the Unknown" |
| Page web | http://www.dechema.de/analytics2013 |
| Contact | DECHEMA e.V., Dr. Rolf Lenke; Tél.: [0049 69 7564 267]; Email.: lenke@dechema.de |
| | |
| 67.ESSFD-1 — 1st European Summer School on Formulation Development |
| Dates | 20 Sep 2013 → 22 Sep 2013 | [ID=513882] |
| Lieu | Dubrovnik, Croatie |
| Page web | http://www.iapchem.org/page.php?page_id=40 |
| Contact | Email.: office@iapchem.org |
| | |
| 68.PCMDDD-3 — 3rd World Conference on Physico Chemical Methods in Drug Discovery and Development |
| Dates | 22 Sep 2013 → 26 Sep 2013 | [ID=513969] |
| Lieu | Dubrovnik, Croatie |
| Page web | http://www.iapchem.org/page.php?page_id=34 |
| Contact | Email.: office@iapchem.org |
| | |
| 69.2nd International Conference and Exhibition on Biowaivers and Biosimilars |
| Dates | 23 Sep 2013 → 25 Sep 2013 | [ID=529682] |
| Lieu | Raleigh, North Carolina, États-Unis |
| Page web | http://www.omicsgroup.com/conferences/biowaivers-biosimilars-2013/index.php |
| Contact | Tél.: [(+1-650-268-9744)]; Email.: biosimilars2013@omicsonline.com |
| | |
| 70.PCMDDD-3 — 3rd World Conference on Physico-Chemical Methods in Drug Discovery and Development |
| Dates | 23 Sep 2013 → 26 Sep 2013 | [ID=518745] |
| Lieu | Dubrovnik, Croatie |
| Page web | http://www.iapchem.org/page.php?page_id=34 |
| | |
| 71.2nd Annual BioPharma Asia Congress |
| Dates | 24 Sep 2013 → 25 Sep 2013 | [ID=549775] |
| Lieu | Singapore, Singapour |
| Organisateur | Oxford Global |
| Page web | http://www.biosimilarsasia-congress1.com/download-agenda-marketing/ |
| | |
| 72.Biosimilars Asia Congress |
| Dates | 24 Sep 2013 → 25 Sep 2013 | [ID=549796] |
| Lieu | Singapore, Singapour |
| Organisateur | Oxford Global |
| Page web | http://www.biosimilarsasia-congress1.com/download-agenda-marketing/ |
| | |
| 73.Cell Culture Asia Congress 2013 |
| Dates | 24 Sep 2013 → 25 Sep 2013 | [ID=549751] |
| Lieu | Singapore, Singapour |
| Organisateur | Oxford Global |
| Page web | http://www.cellcultureasia-congress1.com/download-agenda-marketing/ |
| | |
| 74.Vaccine World China 2013 |
| Dates | 24 Sep 2013 → 26 Sep 2013 | [ID=519119] |
| Lieu | Chengdu, Chine |
| Résumé | Vaccine World China 2013 will be THE DEFINITE meeting place for vaccine leaders from China and all around the world. Produced by the same team behind the successful Vaccine World Summit India, Vaccine World China 2013 promises to be a splendid experience that you do not want to miss. |
| Sujets | vaccine, pharmaceutical, drug development, biotechnology, biotech, biomanufacturing, immunization, vaccinisation |
| Page web | http://www.imapac.com/index.php?page=VaccineWorldChina2013 |
| Contact | Patricia Chong; Tél.: [+65 6493 1871]; Email.: patricia.chong@imapac.com |
| | |
| 75.VWC2013 — Vaccine World China 2013 |
| Dates | 24 Sep 2013 → 26 Sep 2013 | [ID=549542] |
| Lieu | Chengdu, Singapour |
| Sujets | vaccine, health, medicine |
| Page web | http://www.imapac.com/index.php?page=VaccineWorldChina2013 |
| Contact | Tél.: [(6564931871)]; Email.: jen.cheng@imapac.com |
| | |
| 76.Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing |
| Dates | 25 Sep 2013 → 27 Sep 2013 | [ID=550228] |
| Lieu | Boston, États-Unis |
| Organisateur | Scientific Update LLP |
| Page web | http://www.scientificupdate.co.uk/training/scheduled-courses/details/202-Practical Approaches to Quality by Design for Pharmaceutical Process R.html?D_and_Manufacturing= |
| | |
| 77.Hands-on Tablet Development, including the Principles of Pre-formulation, Formulation and Process Development |
| Dates | 26 Sep 2013 → 28 Sep 2013 | [ID=544524] |
| Lieu | Londres, Royaume-Uni |
| Résumé | This unique 3 day course is designed to integrate the key elements of tablet development with hands-on, practical experience in a small scale, lab scale test facility. Each day will consist of lectures on aspects of tablet development, followed by linked sessions in which participants take part in related experimental work.The course enables attendees to apply the theory learnt in the taught sessions, and also to directly observe the effect of formulation on product properties, and relate the theory to the practice of Quality by Design (QbD).
Learning outcomes:
* Understanding of the relationship between Quality by Design, drug substance properties, formulation and process development
* Practical experience of small scale tablet manufacture with direct knowledge of the relationship between formulation properties and tablet compressibility
* Understanding of the roles of critical quality attributes, critical process parameters, and product control strategy in the application of the principles of QbD to formulation development
Who Should Attend?
* Newcomers to tablet formulation development and manufacturing
* Production operators who need a better understanding of their products and how they have been developed
* Analytical and QC staff who would benefit from understanding the tablet development and production process
* Experienced personnel in one area of product development who need a broader overview
* Project team members needing a broader insight into formulation development including preclinical, clinical, and project management representatives
* Regulatory staff who would benefit from brief practical experience of the processes for which they are compiling dossiers
* Regulatory agency staff requiring practical experience |
| Sujets | Quality by Design, QbD, physico-chemical properties, process development and validation, granulation and drying, Critical Process Parameters, Powder and granule characterisation, lubrication and compression |
| Page web | http://www.pharma-training-courses.com/hands-on-tablet-development-including-the-principles-of-pre-formulation-formulation-and-process-dev_28.htm |
| Contact | Judy Callanan; Tél.: [(++44 20 71937703)]; Email.: info@pharma-training-courses.com |
| | |
| 78.Heterogeneous Catalytic Hydrogenation |
| Dates | 30 Sep 2013 → 02 Oct 2013 | [ID=550126] |
| Lieu | Princeton, États-Unis |
| Organisateur | Scientific Update LLP |
| Page web | http://www.scientificupdate.co.uk/training/scheduled-courses.html |
| | |
| 79.9th Annual Project & Portfolio Management in the Pharmaceutical Industry |
| Dates | 01 Oct 2013 → 02 Oct 2013 | [ID=547409] |
| Lieu | Vienne, Autriche |
| Résumé | Increasing budget pressures in the pharma industry, the impact of rising R&D costs and multiple challenges in drug development have led pharma companies to pay far greater attention to their portfolio strategies, resource allocation and decision making processes. Over the course of our 2-day event, attendees will discuss criteria for project prioritization, project diversification, specific risk in pharma projects, soft factors that drive risk evaluation and much more. |
| Sujets | project prioritization, industry and non-industry collaboration, risk evaluation, PPM tools |
| Page web | http://pharma.flemingeurope.com/pharma-ppm-conference |
| Contact | Andrea Weber; Tél.: [+421 257 272 335]; Email.: andrea.weber@flemingeurope.com |
| | |
| 80.9th Annual Quality & OPEX in Pharma & Biotech |
| Dates | 01 Oct 2013 → 02 Oct 2013 | [ID=543461] |
| Lieu | Berlin, Allemagne |
| Résumé | Companies are now looking to Lean Manufacturing and Six Sigma principles to help them boost operational efficiency and improve quality. |
| Sujets | Six Sigma, QbB principles and Pattools, Quality assurance, Quality Risk Management |
| Page web | http://pharma.flemingeurope.com/quality-opex-conference |
| Contact | Andrea Weber; Tél.: [+421 257 272 335]; Email.: andrea.weber@flemingeurope.com |
| | |
| 81.The Design, Development and Scale-Up of Safe Chemical Processes and Operations |
| Dates | 02 Oct 2013 → 04 Oct 2013 | [ID=550081] |
| Lieu | Princeton, États-Unis |
| Organisateur | Scientific Update LLP |
| Page web | http://www.scientificupdate.co.uk/training/scheduled-courses.html |
| | |
| 82.ICAAM 2013 — International Conference on Alternatives to Animal Models |
| Dates | 03 Oct 2013 → 04 Oct 2013 | [ID=549626] |
| Lieu | Kuala Lumpur, Malaisie |
| Résumé | The International Conference on Alternatives to Animal Models (ICAAM 2013) is a platform to exchange ideas, experiences, to showcase innovations and to forge and renew a mutual understanding between international researchers of various professions from the region and beyond in the field of alternatives to animal testing. This prestigious conference is organised by the International Medical University and will be held in Kuala Lumpur, Malaysia during the 3rd and 4th of October, 2013. |
| Sujets | International Conference, Alternatives to Animal Models, Three Rs, biomedical research, alternative research |
| Page web | http://www.imu.edu.my/icaam |
| Contact | Ms Liong Siao Lin / Dr Dinesh Kumar; Tél.: [60 3 2731 7669]; Email.: icl@imu.edu.my / Dinesh_Kumar@imu.edu.my |
| | |
| 83.2013 PDA Analytical Methods Development & Validation Workshop |
| Dates | 07 Oct 2013 → 08 Oct 2013 | [ID=549982] |
| Lieu | Baltimore, États-Unis |
| Page web | http://www.pda.org/amd2013 |
| | |
| 84.2013 PDA Visual Inspection Forum |
| Dates | 07 Oct 2013 → 08 Oct 2013 | [ID=550109] |
| Lieu | Bethesda, États-Unis |
| Page web | http://www.pda.org/visualinspection2013 |
| | |
| 85.Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries |
| Dates | 07 Oct 2013 → 09 Oct 2013 | [ID=550229] |
| Lieu | La Jolla, États-Unis |
| Organisateur | Scientific Update LLP |
| Page web | http://www.scientificupdate.co.uk/training/scheduled-courses/details/193-Chemical-Development-and-Scale-Up-in-the-Fine-Chemical-and-Pharmaceutical-Industries.html |
| | |
| 86.2nd Annual Biomarkers in Drug Discovery & Development |
| Dates | 09 Oct 2013 → 10 Oct 2013 | [ID=550440] |
| Lieu | Berlin, Allemagne |
| Résumé | The 2-day event will focus on Biomarkers as a potential to improve the efficacy, safety and decrease the costs of the drug development processes. Participants will learn how to overcome the barriers which may slow the uptake and diffusion of biomarker-based technologies in the drug discovery and development. Speakers and delegates from Big Pharma will attend. |
| Sujets | drug targets, clinical trials, biomarkers regulations |
| Page web | http://pharma.flemingeurope.com/biomarkers-conference |
| Contact | Andrea Weber; Tél.: [+421 257 272 335]; Email.: andrea.weber@flemingeurope.com |
| | |
| 87.Secrets of Batch Process Scale-Up |
| Dates | 09 Oct 2013 → 11 Oct 2013 | [ID=550157] |
| Lieu | Barcelona, Espagne |
| Organisateur | Scientific Update LLP |
| Page web | http://www.scientificupdate.co.uk/training/scheduled-courses.html |
| | |
| 88.IAOC — V InterAmerican Oncology Conference: 'Status and Future of Anti-Cancer Targeted Therapies' |
| Dates | 10 Oct 2013 → 11 Oct 2013 | [ID=508911] |
| Lieu | Buenos Aires, Argentine |
| Résumé | The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development. The major emphasis will be on clinical aspects of cancer treatment in the 21st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development. |
| Sujets | Oncology - Cancer Conference, Renal Cancer, Prostate Cancer, Lung Cancer, Ovarian Cancer, Gi and Gu Cancer, New Anticancer Therapies, Drug development Updates, Leukemia, Lymphoma, Myeloma, Sarcoma, Melanoma, Cancer Research, Promising novel agents in early clinical trials, Molecular markers, PI3K-T0R pathways inhibitors, Head and Neck cancer. |
| Page web | http://www.oncologyconferences.com.ar |
| Contact | Secretariat; Email.: oncology@oncologyconferences.com.ar |
| Sujets apparentés | Cancérologie |
| | |
| 89.World ADC San Francisco 2013 |
| Dates | 14 Oct 2013 → 17 Oct 2013 | [ID=549668] |
| Lieu | San Francisco, États-Unis |
| Organisateur | Hanson Wade |
| Page web | http://adc-summit.com/ |
| | |
| 90.4th International Conference and Exhibition on Analytical & Bioanalytical Techniques |
| Dates | 15 Oct 2013 → 17 Oct 2013 | [ID=530626] |
| Lieu | Las Vegas, NV, États-Unis |
| Résumé | OMICS Group invites you to attend the 4th International Conference and Exhibition on Analytical & Bioanalytical Techniques during Oct 15-17, 2013 at Hampton Inn Tropicana, Las Vegas, NV, USA. We welcome all the participants from across the world to take part in this premier event. |
| Sujets | Novel Approaches to Analytical & Bioanalytical Methods, Analytical Methodology, Bio-analytical Methodology, Analytical Techniques in Pharmacology, Regulatory Issues and Biosafety Challenges in Bioanalysis, Advances in Mass Spectrometry, Environmental Analytical Aspects, Risk Monitoring in Bioanalysis, Applications of Analytical and Bioanalytical Methods, Analytical Techniques in Immuno Chemistry |
| Page web | http://www.omicsgroup.com/conferences/analytical-bioanalytical-techniques-2013/ |
| Contact | Tél.: [(888-843-8169)]; Email.: analytica2013@omicsgroup.com |
| Sujets apparentés | Chimie analytique; Biochimie et chimie médicale |
| | |
| 91.Chemical Development & Scale-Up in the Fine Chemical and Pharmaceutical Industries |
| Dates | 16 Oct 2013 → 18 Oct 2013 | [ID=550156] |
| Lieu | Lisbonne, Portugal |
| Organisateur | Scientific Update LLP |
| Page web | http://www.scientificupdate.co.uk/training/scheduled-courses.html |
| | |
| 92.Integrated Continuous Biomanufacturing |
| Dates | 20 Oct 2013 → 24 Oct 2013 | [ID=542370] |
| Lieu | Castelldefels, Espagne |
| Résumé | In the 20th century the successful implementation of continuous process technologies has revolutionized multiple industries , such as petrochemical , steel , glass , paper , food and pharmaceutical. The strategic advantages of continuous processing include steady-state operation , high productivity, elimination of non-value-aded unit operations , shortened process cycle times , minimized process scale - up requirements , and an order -of-magnitude decrease in equipment/facility size.These advantages should be fully transferable to bioprocessing and are especially attractive given the increasing pressure to rapidly develope efficient and robust processes for manufacturing next generation biotherapeutics. Integrated continuous processing could deliver a transformative impact on biotechnology. This inaugural Integrated Continuous Biomanufacturing conference will review the state of the art technology and emerging trends in all related areas , including cell culture , purification, facility design, process architecture, business modeling , and regulatory considerations. Particular attention will be given to recombinant theraputic protein manufacturing in mammalian cell culture, but the conference scope will be broad enough to embrace other relevant biotechnology fields, including vaccines , stem cells , and microbial culture. |
| Page web | http://www.engconfintl.org/13aqabout.html |
| Contact | Arlene Conway ; Tél.: [12125146760]; Email.: arlene@engconfintl.org |
| | |
| 93.3rd International Conference on Pharmaceutical Regulatory Affairs |
| Dates | 21 Oct 2013 → 23 Oct 2013 | [ID=550038] |
| Lieu | San Francisco, États-Unis |
| Organisateur | Omics Group Conferences |
| Page web | http://www.omicsgroup.com/conferences/pharmaceutical-regulatory-affairs-2013/index.php |
| | |
| 94.PDA 8th Annual Global Conference on Pharmaceutical Microbiology |
| Dates | 21 Oct 2013 → 23 Oct 2013 | [ID=550079] |
| Lieu | Bethesda, États-Unis |
| Page web | http://www.pda.org/microbiology2013 |
| | |
| 95.A Chemist's Guide to Chemical Engineering |
| Dates | 22 Oct 2013 → 25 Oct 2013 | [ID=550144] |
| Lieu | Nice, France |
| Organisateur | Scientific Update LLP |
| Page web | http://www.scientificupdate.co.uk/training/scheduled-courses.html |
| | |
| 96.The Pharma Market Access Pricing and Reimbursement Conference |
| Dates | 23 Oct 2013 → 24 Oct 2013 | [ID=550063] |
| Lieu | San Francisco, États-Unis |
| Organisateur | Arrowhead Publishers and Conferences |
| Page web | http://www.pharmamarketaccessconference.com/index.php/brochure |
| | |
| 97.Biocatalysis as a Tool for the Synthetic Chemist |
| Dates | 29 Oct 2013 → 30 Oct 2013 | [ID=550176] |
| Lieu | Barcelona, Espagne |
| Organisateur | Scientific Update LLP |
| Page web | http://www.scientificupdate.co.uk/training/scheduled-courses.html |
| | |
| 98.International Conference on Functional and Comparative Genomics & Pharmacogenomics |
| Dates | 12 Nov 2013 → 14 Nov 2013 | [ID=529154] |
| Lieu | Chicago, États-Unis |
| Résumé | OMICS Group invites all the participants across the globe to attend the International Conference on Functional and Comparative Genomics & Pharmacogenomics during November 12-14, 2013 in Chicago-North Shore, USA. Genomics-2013 will provide excellent opportunity to geneticists/genome researchers/health care industrialists to discuss modern approaches, techniques, discoveries and their applications in the field of Genomics. Genomics-2013 will focus on Functional and Comparative genomics, Pharmacogenomics, Evolutionary Genomics, Biomarkers and Molecular Markers, Sequencing and Mapping, Proteomics and Cancer Genomics and Computational Genomics and Proteomics. International conference on Functional and Comparative Genomics & Pharmacogenomics, will be organized around the theme "Recent Research Methodologies and Discoveries in Genomics Era". |
| Sujets | Life Science, Medical & Health, Genomics, Proteomics, Bioinformatics, Pharmacogenomics |
| Page web | http://www.omicsgroup.com/conferences/functional-comparative-genomics-2013/ |
| Contact | 5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354; Tél.: [+1-650-268-9744]; Email.: genomics2013@esciencecentral.org |
| Sujets apparentés | Biologie moléculaire; Génomique et bio-informatique |
| | |
| 99.2nd International Summit on GMP, Quality Control and Validation |
| Dates | 12 Nov 2013 → 14 Nov 2013 | [ID=549973] |
| Lieu | Chicago, États-Unis |
| Page web | http://www.omicsgroup.com/conferences/gmp-quality-control-validation-2013/ |
| | |
| 100.PDA/FDA Advanced Technologies for Virus Detection in the Evaluation of Biologicals Conference |
| Dates | 13 Nov 2013 → 14 Nov 2013 | [ID=550099] |
| Lieu | Bethesda, États-Unis |
| Page web | http://www.pda.org/virusdetection2013 |
| | |
| 101.2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials |
| Dates | 18 Nov 2013 → 19 Nov 2013 | [ID=529609] |
| Lieu | San Antonio, États-Unis |
| Résumé | With the great success of Pharmacovigilance-2012, OMICS Group proudly announces, 2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials, which will bring together a unique and International mix of Pharmaceutical, Biotech and Clinical research companies, leading Universities and Research Institutes working in the field of Pharmacovigilance and drug safety, making the Conference a perfect platform to share experience, foster collaborations across industry and academia and share emerging scientific updates across the globe by means of thought provoking Keynote presentations, oral talks and poster presentations opportunities. |
| Sujets | Pharmacovigilance and its Challenges, Role of Clinical Trials, Clinical Trials on Diseases, Adverse Drug Reactions, Drug Interactions, Pharmacy Practices and Its Challenges, Regulatory Affairs, Risk Management: New Approaching Paradigm for Pharmacovigilance, Clinical Research and Statistics, Strategies for Growth in Pharma Environment. |
| Page web | http://www.omicsgroup.com/conferences/pharmacovigilance-clinical-trials-2013/index.php |
| Contact | Isaac; Email.: pharmacovigilance2013@omicsgroup.com |
| | |
| 102.3rd World Congress on Cell Science & Stem Cell Research |
| Dates | 20 Nov 2013 → 22 Nov 2013 | [ID=549998] |
| Lieu | Baltimore, États-Unis |
| Organisateur | OMICS Publishing group |
| Page web | http://www.omicsgroup.com/conferences/cellscience-2013/venue.php |
| | |
| 103.Fixed Combination 2013 — The 5th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus |
| Dates | 21 Nov 2013 → 25 Nov 2013 | [ID=539767] |
| Lieu | Bangkok, Thaïlande |
| Résumé | Fixed combination has recently made a comeback as an initial therapy in the treatment of hypertension. The additive or synergistic effect of combination therapy fully lowers blood pressure in patients who tend to have less than full response to one component only. Antihypertensive monotherapy does not address the multifactorial nature of hypertension as a disease with many pathways; using more than one drug makes more therapeutic sense, as combined agents cover more than one etiology. |
| Sujets | Hypertension, Obesity, Diabetes, pharmaceuticals |
| Page web | http://www.fixedcombination.com |
| Contact | Noa Beer-Raveh; Tél.: [41 22 5330 948]; Email.: fixed2013@fixedcombination.com |
| Sujets apparentés | Médecine (en général) |
| | |
| 104.AIC2013 — Autumn Immunology Conference |
| Dates | 22 Nov 2013 → 25 Nov 2013 | [ID=535798] |
| Lieu | Chicago , États-Unis |
| Résumé | Join us as the Autumn Immunology Conference enters its 42nd year! Founded in 1972, the annual meeting features plenary sessions presented by outstanding immunologists as well as offering a forum for students and trainees to present their latest findings in both workshop and poster formats. |
| Page web | http://www.autumnimmunology.org/index.php |
| Inscription via COMS | https://www.conference-service.com/AIC2013/welcome.cgi |
| Sujets apparentés | Médecine (en général) |
| | |
| 105.First International Therapeutics Discovery Symposium-Asia-2013 on ‘Small RNAs to Stem Cells & Epigenetic Reprograming Asia-2013 Meeting.’ |
| Dates | 25 Nov 2013 → 26 Nov 2013 | [ID=535983] |
| Lieu | Tokyo, Japon |
| Sujets | RNAi, microRNAs, siRNA delivery, Non-coding RNAs, piRNAs, microRNAs in disease biology, stem cell biology, pluripotent stem cells, induced pluripotent stem cells, Stem Cell Therapy, Epigenetics-based Therapeutics, Chromatin Biology, Nuclear dynamics |
| Page web | http://www.expressgenes.com |
| Contact | Tél.: [781-891-8181]; Email.: sham@expressgenes.com |
| | |
| 106.BPI 2013 — BioPharma India Convention 2013 |
| Dates | 25 Nov 2013 → 26 Nov 2013 | [ID=548646] |
| Lieu | Singapore, Singapour |
| Résumé | Biopharma India 2013 is the region’s leading industry event where more than 300 manufacturing, clinical trials and supply chain stakeholders across India and beyond come together to identify innovation and partnership opportunities as well as best business and operationally effective practices in India’s biopharmaceutical industry. |
| Page web | http://www.terrapinn.com/conference/biopharma-india/index.stm |
| Contact | Rebecca Koh; Tél.: [+65 6322 2725]; Email.: rebecca.koh@terrapinn.com |
| | |
| 107.Organic Synthesis: A Toolkit for the Industrial Chemist |
| Dates | 26 Nov 2013 → 28 Nov 2013 | [ID=550175] |
| Lieu | Florence, Italie |
| Organisateur | Scientific Update LLP |
| Page web | http://www.scientificupdate.co.uk/training/scheduled-courses/details/153-organic-synthesis.html |
| | |
| 108.BioPharma India Convention 2013 |
| Dates | 03 Dec 2013 → 04 Dec 2013 | [ID=542756] |
| Lieu | Singapore, Singapour |
| Résumé | Biopharma India 2013 is the region’s leading industry event where more than 300 manufacturing, clinical trials and supply chain stakeholders across India and beyond come together to identify innovation and partnership opportunities as well as best business and operationally effective practices in India’s biopharmaceutical industry. |
| Page web | http://www.terrapinn.com/conference/biopharma-india/index.stm |
| | |
| 109.Validation of Analytical Methods for Pharmaceutical Analysis. |
| Dates | 04 Dec 2013 → 05 Dec 2013 | [ID=549850] |
| Lieu | Berlin, Allemagne |
| Organisateur | Mourne Training Services |
| Page web | http://www.mournetrainingservices.co.uk/course_list.html |
| | |
| 110.Hands-on Tablet Development, including the Principles of Pre-formulation, Formulation and Process Development |
| Dates | 04 Dec 2013 → 06 Dec 2013 | [ID=544534] |
| Lieu | Londres, Royaume-Uni |
| Résumé | This unique 3 day course is designed to integrate the key elements of tablet development with hands-on, practical experience in a small scale, lab scale test facility. Each day will consist of lectures on aspects of tablet development, followed by linked sessions in which participants take part in related experimental work.The course enables attendees to apply the theory learnt in the taught sessions, and also to directly observe the effect of formulation on product properties, and relate the theory to the practice of Quality by Design (QbD).
Learning outcomes:
* Understanding of the relationship between Quality by Design, drug substance properties, formulation and process development
* Practical experience of small scale tablet manufacture with direct knowledge of the relationship between formulation properties and tablet compressibility
* Understanding of the roles of critical quality attributes, critical process parameters, and product control strategy in the application of the principles of QbD to formulation development
Who Should Attend?
* Newcomers to tablet formulation development and manufacturing
* Production operators who need a better understanding of their products and how they have been developed
* Analytical and QC staff who would benefit from understanding the tablet development and production process
* Experienced personnel in one area of product development who need a broader overview
* Project team members needing a broader insight into formulation development including preclinical, clinical, and project management representatives
* Regulatory staff who would benefit from brief practical experience of the processes for which they are compiling dossiers
* Regulatory agency staff requiring practical experience |
| Sujets | Quality by Design, QbD, physico-chemical properties, process development and validation, granulation and drying, Critical Process Parameters, Powder and granule characterisation, lubrication and compression |
| Page web | http://www.pharma-training-courses.com/hands-on-tablet-development-including-the-principles-of-pre-formulation-formulation-and-process-dev_28.htm |
| Contact | Judy Callanan; Tél.: [(++44 20 71937703)]; Email.: info@pharma-training-courses.com |
| | |
| 111.How to Develop Stability Indicating HPLC Methods |
| Dates | 09 Dec 2013 → 10 Dec 2013 | [ID=549937] |
| Lieu | Berlin, Allemagne |
| Organisateur | Mourne Training Services |
| Page web | http://www.mournetrainingservices.co.uk/course_list.html |
| Sujets apparentés | Formation en chromatographie (GC, HPLC, UPLC) |
| | |
| 112.BPA 2014 — BioPharma Asia Convention 2014 |
| Dates | 10 Mar 2014 → 13 Mar 2014 | [ID=548636] |
| Lieu | Singapore, Singapour |
| Résumé | The 7th annual BioPharma Asia Convention has establishes itself as the leading industry platform in Asia for pharmas, biotechs, CROs, CMOs, research institutes, investors and all other industry stakeholders to meet, network and discuss latest industry trends, partnership models and investment opportunities in Asia. |
| Page web | http://www.terrapinn.com/exhibition/bio-asia/ |
| Contact | Gladys Leong; Tél.: [+65 6322 2705]; Email.: gladys.leong@terrapinn.com |
| | |
| 113.BioPharma Asia Convention 2014 |
| Dates | 17 Mar 2014 → 20 Mar 2014 | [ID=542725] |
| Lieu | Singapore, Singapour |
| Résumé | With 6 conferences in 1, BioPharma Asia Convention 2014 is the definitive marketplace featuring the latest solutions and strategy driving growth across Asia's biopharma industry. |
| Page web | http://www.terrapinn.com/exhibition/bio-asia/ |
| | |
| 114.CELL CULTURE ENGINEERING XIV |
| Dates | 04 Mai 2014 → 09 Mai 2014 | [ID=542657] |
| Lieu | Qubec City, Canada |
| Résumé | Since 1988 the Cell Culture Engineering conferences have been held bi-annually and have developed into the leading global venue for the academic, industrial and regulatory communities for intensive interactions and debates to create solutions for improving human health and life by enabling rapid development and high quality manufacturing of an ever increasing number of viral vaccines, recombinant proteins and monoclonal antibodie. The 2014 conference will be the 14th conference in this highly successful series. This Cell Culture Engineering XIV Conference will bring together 300 selected participats of top academic, industrial and governmental researchers from all over the world. This conference program will focus on topics ranging from the frontiers of fundamental biologic science around animal cells, the engineering challenges of cell culture process development and implementation, the latest regulatory concepts such as QbD and design space for improving process design and product quality, strategies for accelerating development of high quality and cost effective biosimilars and opportunities for international collaborations. |
| Page web | http://www.engconfintl.org/14ac.html |
| Contact | Arlene Conway; Tél.: [1-212-514-6760]; Email.: arlene@engconfintl.org |
| | |
